Enhancement of immunoglobulin G2A and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice
Mk. Song et al., Enhancement of immunoglobulin G2A and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice, J VIROLOGY, 74(6), 2000, pp. 2920-2925
The induction of strong cytotoxic T-lymphocyte (CTL) and humoral responses
appear to be essential for the elimination of persistently infecting viruse
s, such as hepatitis C virus (HCV). Here, we tested several vaccine regimen
s and demonstrate that a combined vaccine regimen, consisting of HCV E2 DNA
priming and boosting with recombinant E2 protein, induces the strongest im
mune responses to HCV E2 protein. This combined vaccine regimen augments E2
-specific immunoglobulin G2a (IgG2a) and CD8(+) CTL responses to a greater
extent than immunizations with recombinant E2 protein and E2 DNA alone, res
pectively. In addition, the data showed that a protein boost following one
DNA priming was also effective, but much less so than those following two D
NA primings, These data indicate that sufficient DNA priming is essential f
or the enhancement of DNA encoded antigen-specific immunity by a booster im
munization with recombinant E2 protein. Furthermore, the enhanced CD8(+) CT
L and IgG2a responses induced by our combined vaccine regimens are closely
associated with the protection of BALB/c mice from challenge with modified
CT26 tumor cells expressing HCV E2 protein. Together, our results provide i
mportant implications for vaccine development for many pathogens, including
HCV, which require strong antibody and CTL responses.